Abstract:OBJECTIVE—Our previous study suggests that Cidea, a member of Cide family proteins that share sequence homology with the DNA fragmentation factor and are expressed at high levels in brown adipose tissue, plays an important role in the development of obesity. Cideb, another member of Cide family protein, is highly expressed in the liver. We would like to understand the physiological role of Cideb in the regulation of energy expenditure and lipid metabolism. RESEARCH DESIGN AND METHODS—We generated Cideb-null mice by homolog recombination and then fed both wild-type and Cideb-null mice with high-fat diet (58% fat). We then characterized the animals’ adiposity index, food intake, whole-body metabolic rate, liver morphology, rate of fatty acid synthesis and oxidation, insulin sensitivity, and gene expression profile. RESULTS—Cideb-null mice had lower levels of plasma triglycerides and free fatty acids and were resistant to high-fat diet–induced obesity and live steatosis. In addition, Cideb mutant mice displayed significantly increased insulin sensitivity and enhanced rate of whole-body metabolism and hepatic fatty acid oxidation. More importantly, Cideb-null mice showed decreased lipogenesis and reduced expression levels of acetyl-CoA carboxylase, fatty acid synthase, and stearol-CoA desaturase. We further demonstrated that expression levels of sterol response element binding protein 1c was significantly decreased in Cideb-deficient mice. CONCLUSIONS—Our data demonstrate that Cideb is a novel important regulator in lipid metabolism in the liver. Cideb may represent a new therapeutic target for the treatment of obesity, diabetes, and liver steatosis.

Control of Lipid Droplet Fusion and Growth by CIDE Family Proteins

CIDE proteins and their regulatory mechanisms in lipid droplet fusion and growth

CIDE Proteins and Lipid Metabolism.

Differential Roles of Cell Death-inducing DNA Fragmentation Factor-α-like Effector (CIDE) Proteins in Promoting Lipid Droplet Fusion and Growth in Subpopulations of Hepatocytes

C CIDE proteins and metabolic dis orders

CIDE Proteins and Metabolic Disorders

Cidea controls lipid droplet fusion and lipid storage in brown and white adipose tissue

Polybasic RKKR Motif in the Linker Region of Lipid Droplet (ld)–associated Protein CIDEC Inhibits LD Fusion Activity by Interacting with Acidic Phospholipids

Opposing roles of cell death-inducing DFF45-like effector B and perilipin 2 in controlling hepatic VLDL lipidation

The Role of Cell-Death-inducing DNA-fragmentation-factor-like Effector (cide)family in TG Metabolism

A gel-like condensation of Cidec generates lipid-permeable plates for lipid droplet fusion

PI(4)P Recruits CIDE Proteins to Promote the Formation of Unilocular Lipids Droplets

Cideb Facilitates the Lipidation of Chylomicrons in the Small Intestine.

Imaging lipid droplet fusion and growth.

PI(4)P recruits CIDE proteins to promote the formation of unilocular lipid droplets during adipogenesis and hepatic steatosis

Relationship between the Cell Death-Inducing DNA Fragmentation Factor 45-Like Effector Protein Family and the Risk of Dyslipidemia

Cidec differentially regulates lipid deposition and secretion through two tissue-specific isoforms.

Geometry-Constrained Cidec Phase Separation Generates Lipid Permeable Plates for Lipid Droplet Fusion

Cideb Regulates Diet-Induced Obesity, Liver Steatosis, and Insulin Sensitivity by Controlling Lipogenesis and Fatty Acid Oxidation

Coordination among Lipid Droplets, Peroxisomes, and Mitochondria Regulates Energy Expenditure Through the CIDE-ATGL-PPARα Pathway in Adipocytes.

Paxillin Family Proteins Hic-5 and LPXN Promote Lipid Storage by Regulating the Ubiquitination Degradation of CIDEC.